Introduction
Green analytical chemistry provides development of various analytical procedures and methods with a minimal impact on operators and the environment. Green sample pretreatment approaches, especially microextraction, have attracted great attention as they lead inherently to minimum solvent and reagent consumption, and drastic reduction of laboratory wastes [1] . Liquid-phase microextraction (LPME) has grown increasingly popular due to its simplicity, low cost, adaptability to a wide variety of sample types and analytes, as well as, for all major analytical instrumentation [2] . The most frequently used LPME modes are: single-drop microextraction [3, 4] , hollow-fiber liquid-phase microextraction [5e7], dispersive liquideliquid microextraction [8] , solidified floating organic drop microextraction [9] . All these modes are well described in numerous reviews where the main benefits and drawbacks are presented [1,6,10e13] .
Recently, the group of M. Valcarcel suggested two novel approaches for LPME. The first is so-called effervescence assisted dispersive liquideliquid microextraction (EA-DLLME), in which the extraction process is encouraged by effervescence effect resulting from in-situ carbon dioxide generation [14] . The second is based on the use of so-called switchable hydrophilicity solvents (SHS) for microextraction [15, 16] . These solvents (usually amidines and secondary/tertiary amines) can be switched between hydrophobic and hydrophilic forms, depending on the solution composition [17] . Both procedures were further developed also by other authors [18e20] . Just a few months ago, Jen et al. (2015) presented the application of medium-chain fatty acid as extraction solvent (hydrophobic form) for LPME [21] . This solvent can be switched between hydrophobic and hydrophilic forms by the adjustment of pH of the solution. Thus, in fact, medium-chain fatty acids can also be considered as SHS.
To the best of our knowledge, the above-mentioned procedures were carried out manually, and no automated procedures were reported. Flow analysis can be considered as a superior tool for automation of wide variety of analytical procedures, including microextraction [22e30] .
Therefore, the aim of this study was to hyphenate the effervescence-assisted microextraction with switchable hydrophilicity solvents microextraction, and automate the hyphenated procedure. The combined method, effervescence-assisted switchable solvent-based liquid phase microextraction (EA-SS-LPME), assumes using medium-chain fatty acids as extractant. Furthermore, sodium carbonate was used on one hand, to induce conversion of fatty acid from water-immiscible to water-miscible form, and on the other hand, to provide effervescence, while its excess reacts with a mineral acid. In this case, the effervescence increases the efficiency of extraction and phase separation. To demonstrate the efficiency of the suggested approach, the automated EA-SS-LPME procedure was applied to determine fluoroquinolone antibacterial agent, ofloxacin (OFLX) as a proof-of-concept analyte in human urine samples, using HPLC with fluorescence detection (HPLC-FLD).
Experimental

Reagents and solutions
All chemicals and reagents were of analytical grade. Ultra pure water from Millipore Milli-Q RG (Millipore, USA) was used. Fatty acids (nonanoic, hexanoic and pivalic acids), ofloxacin and methanol were purchased from SigmaeAldrich. 
Manifold and apparatus
The manifold for automated EA-SS-LPME procedure ( Fig. 1 ) consists of two eight-port selection valves (Sciware Systems SL, Spain), a 2. An RF-5301 PC spectrofluorometer (Shimadzu, Japan) equipped with 10 mm quartz cell was used for the preliminary studies and for the spectrofluorimetric determination of OFLX.
Samples and sample preparation
Human urine samples were collected from fasting and healthy three volunteers in the morning. Before analysis, the urine samples were filtered through a 0.45 mm membrane filter. Spiked samples were prepared by addition of calculated volumes of working solutions of OFLX to filtrated blank urine samples so that the volume of resulting solutions was 1 mL. The samples were left to stand for 30 min, to allow interaction between the analyte and the urine matrix. Before analysis, the samples were diluted ten-fold three times, and appropriate aliquot of this solution was used for the analysis.
The procedure for automated determination of ofloxacin in human urine samples
At the first stage, 350 mL of 2 mol L À1 Na 2 CO 3 (port 1, valve 1), 1 mL of diluted urine sample (port 2, valve 1) and 50 mL of hexanoic acid (port 3, valve 1) were sequentially aspirated to the mixing coil by the syringe pump. While reagents were passing through the mixing coil, formation of homogeneous solution of sodium hexanoate, OFLX and excess carbonate ions took place. Afterwards, the resulting mixture was delivered (port 4, valve 1) into the mixing chamber using the syringe pump. In order to clean the mixing coil from sodium carbonate residues, it was washed out by water (port 5, valve 1) twice. 260 mL of 2.5 mol L À1 H 2 SO 4 (port 6, valve 1) was aspirated to the mixing coil and delivered into the mixing chamber. Addition of sulfuric acid solution led to conversion of the water-miscible hexanoate ions into hydrophobic hexanoic acid, effervescence-assisted microextraction of OFLX and phase separation.
Afterwards, the aqueous phase was moved to waste (port 7, valve 1), while organic phase remained in the mixing chamber.
Then, 450 mL of phosphate buffer (pH 6.4) and methanol mixture (1:1, v/v) (port 11, valve 2) was delivered into the mixing chamber by the peristaltic pump for dissolving hexanoic acid, containing the extracted analyte for HPLC analysis. The mixture was mixed by air bubbles (port 12, valve 2) for 20 s.
The obtained solution was aspirated (port 14, valve 2) to chromatographic vial using peristaltic pump and analyzed by HPLC-FLD. The fluorescence excitation and emission wavelengths were 293 and 502 nm, respectively. The chromatographic separation was achieved by SUPELCO C18 column (250 mm Â 4.6 mm, 5 mm) with phosphate buffer (pH 6.4) and methanol mixture (1:1, v/v) at mobile phase flow-rate of 0.7 mL min
À1
. The chromatograph was operated at ambient temperature. The EA-SS-LPME procedure is presented in video.
Supplementary data related to this article can be found online at http://dx.doi.org/10.1016/j.aca.2015.12.004.
2.5. The procedure for spectrofluorimetric determination of ofloxacin in human urine samples 2 mL of BrittoneRobinson buffer (pH 4.0) and 0.4 mL of sodium dodecyl sulfate (7.5%) and polyoxyethylene(7.5)nonylphenylether (5%) solution were added to 10 mL of urine sample and the mixture was mixed properly and added with 0.6 g of NaCl. The mixture was centrifuged for 15 min at 3000 rpm and placed in an ice bath for 10 min. The micellar phase containing the ofloxacin was separated as a solid phase at the bottom of the tube and the aqueous phase was poured off by inversion. The micellar phase in the tube was then diluted with 0.2 mL of ethanol. The solution was transferred into a quartz cell and the fluorescent intensity was measured (lex ¼ 299 nm, lem ¼ 496 nm) [31] .
Results and discussion
Theoretical considerations of EA-SS-LPME concept
The mechanism of proposed EA-SS-LPME procedure can be presented by two consecutive steps (Fig. 2) . The first step (A and B) includes an addition of hexanoic acid to the aqueous sample and conversion of water-immiscible hexanoic acid to its ionic (hydrophilic) form by addition of sodium carbonate solution. As a result, a homogeneous solution is formed. Approximately, 99.9% of hexanoic acid is dissociated into its anion form as an anionic surfactant in alkaline sodium carbonate solution (the pKa of hexanoic acid is 4.85 [32] ). It should be pointed out that sodium carbonate is added in excess due to its triple role in the extraction process as an alkaline and disperser agent, as well as, a phase separation intensifier.
In the second step, after the addition of sulfuric acid solution (C and D), extraction takes place as a result of two chemical processes which occur simultaneously: (1) decreasing pH induces the conversion of sodium hexanoate to microdroplets of hexanoic acid (in this step OFLX is transferred to organic phase); (2) moreover, the effervescence takes place due to the reaction of sulfuric acid with excess sodium carbonate, and carbon dioxide bubbles generated insitu promote the extraction process and final phase separation. Thus, the whole extraction process proceeds only by simple changing of pH value.
Investigation of appropriate conditions of EA-SS-LPME
Effect of extraction solvent type
Three medium-chain saturated fatty acids (nonanoic, hexanoic and pivalic) were studied. All of them have switchable behavior and can be dissociated into a hydrophilic form at a pH higher than their pKa. The applicability of these fatty acids for EA-SS-LPME was investigated by adding 50 mL of each fatty acid to1 mL of 0.5$10 À6 mol L À1 of aqueous solution of OFLX, followed by adding 350 mL of 2 mol L À1 Na 2 CO 3 and 260 mL of 2.5 mol L À1 H 2 SO 4 . While Fig. 1 . The manifold for automated EA-SS-LPME system coupled with HPLC-FLD for the determination of ofloxacin in human urine samples. Fig. 2 . The EA-SS-LPME process diagram.
using the pivalic acid, poor recovery of fatty acid was observed because of its relatively high solubility. The nonanoic and hexanoic acids have shown satisfactory results of extraction and phase separation efficiency. However, the nonanoic acid needs larger volume of mobile phase to be dissolved. Thus, hexanoic acid was selected for further research.
Effect of SHS volume
To find the optimal volume of SHS, 1 mL of 0.5$10 À6 mol L À1 aqueous OFLX solution was extracted by various volumes of hexanoic acid from 25 to 100 mL according to the procedure presented in Section 2.4. It was found that the SHS volume less than 50 mL led to poor recovery (ESI Fig. A) . Thus, the volume of 50 mL of hexanoic acid was selected for further studies.
Effect of volume of sodium carbonate solution
The addition of Na 2 CO 3 led to the conversion of hexanoic acid to an anionic surfactant À sodium hexanoate. The higher the volume of Na 2 CO 3 solution added, the higher the degree of conversion achieved. It is important to take into consideration that sodium carbonate also acts as alkaline, disperser agent, as well as, a phase separation intensifier. To find the optimal extraction efficiency, the volume of 2 mol L À1 Na 2 CO 3 was varied from 250 to 450 mL. The value of 350 mL of Na 2 CO 3 solution resulted in the maximum EA-SS-LPME efficiency (ESI Fig. B) , thus, it was chosen for subsequent studies.
Effect of sample volume
The sample's volume was varied from 0.25 to 1.5 mL. It was found that, the sample volume of 1 mL provides effective extraction (ESI Fig. C) and it was chosen as optimal for further experiments.
Effect of mineral acid type
A mineral acid was used to convert sodium hexanoate into hydrophobic hexanoic acid, and to provide effervescence (the reaction with excess Na 2 CO 3 ). Three mineral acids: sulfuric, phosphoric and hydrochloric acids were investigated. According to our results, sulfuric acid significantly increased the extraction efficiency in comparison with hydrochloric or phosphoric acid (Fig. 3A) ; thus, it was selected for further studies.
Effect of pH
The pH of extraction solution after adding sulfuric acid solution has a great influence on extraction efficiency. It is known that OFLX exists in different forms, depending on pH [33] . The results in Fig 3B indicate that pH less than 6.0 result in sharp decrease of extraction efficiency because OFLX in this condition, exists in protonated form. This ionic form is consequently soluble in water and remains in aqueous phase during the extraction process. At pH values exceeding 7.0, the formation of organic phase is not observed because of complete dissociation of hexanoic acid. Therefore, optimal pH was 6.0.
Effect of sodium carbonate and sulfuric acid concentrations
The concentrations of sodium carbonate and sulfuric acid were varied from 0.5 to 3 mol L À1 for both reagents (Fig. 3C) . Low values of them were characterized by small peak areas and high RSDs due to formation of emulsion. Peak areas were increased and RSDs were decreased, with rising of sodium carbonate concentration, and then became constant at 2 mol L
À1
, which was selected as optimal concentration. It was found that 2.5 mol L À1 H 2 SO 4 can be considered as optimal for analysis.
Interference effect
The effect of the main urine components on automated EA-SS-LPME coupled with HPLC-FLD determination of OFLX was also investigated. It was performed by addition of known concentration of the following possible components of urine: Cl À , NO and NO À 3 . To eliminate the interference effect of the urine components, samples were diluted 1000 folds before the analysis.
Analytical performance
To evaluate the feasibility of the developed EA-SS-LPME, parameters including the linear range, LOD, regression coefficient and repeatability were studied under the optimized conditions. The calibration curve constructed by plotting the peak area against five , respectively. A univariant optimization approach was used to deeply study all the variables involved in the procedure. Although, this method requires a great number of experiments, it allows obtaining detailed information about the EA-SS-LPME. A summary of the optimized conditions used is presented in Table 2 . The active therapeutic concentration of OFLX in urine is from 5$10 À4 mol L À1 to 2$10 À3 mol L À1 [34] . The sample preparation of the developed method includes urine sample predilution and the obtained concentration of OFLX can be determined by the established linear range.
Application for analysis of real samples
The proposed procedure was applied to the analysis of human urine samples. The obtained results showed no significant differences in OFLX concentration obtained by the suggested and the method described in Section 2.5 [31] . (Table 3 ). Student's t-test of statistical hypotheses about the equality of means was used to test the equality of the means of the experimental data obtained by developed method and by the spectrofluorimetric method with cloud-point extraction [31] . Hypothesis about the equality of the means of the experimental data obtained by the developed method and by the spectrofluorimetric method was taken as the null hypothesis (H 0 ). Hypothesis about the difference of mentioned means was taken as an alternative hypothesis (H 1 ). The significance was taken equal to the 0.05 level. Based on the obtained results, the observed differences were not contrary to the H 0 hypothesis and the obtained discrepancies with the 0.05 significance level could be considered insignificant.
Conclusion
A novel fully automated effervescence-assisted switchable solvent-based liquid phase microextraction procedure was developed and applied in the determination of fluoroquinolone antibacterial agent ofloxacin in human urine samples. The benefits of the effervescence-assisted microextraction and switchable hydrophilicity solvents microextraction have been combined. The sodium carbonate was used as the hydrophilicity modifier for fatty acid, as the effervescence agent and as the phase separation intensifier providing in-situ generation of CO 2 . The extraction process required only 2 min to extract analyte from 1 mL of sample solution and utilized only 50 mL of hexanoic acid. Thus, the automated effervescence-assisted switchable solvent-based liquid phase microextraction approach can be considered as a green, rapid, simple, cheap and convenient. EA-SS-LPME HPLC-FLD e effervescence-assisted switchable solvent-based liquid phase microextraction followed by high-performance liquid chromatography with fluorescence detection with fluorescence detection; CE SFL e cloud-point extraction followed by spectrofluorimetry.
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